{
  "id": "5abce6acfcf4565872000022",
  "type": "list",
  "question": "Please list 7 classes of drugs that interact with Warfarin.",
  "ideal_answer": "The number of drugs reported to interact with warfarin continues to expand. There are reports of interactions with azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors, selective serotonin reuptake inhibitors, omeprazole, lipid-lowering agents, protease inhibitors, amiodarone, fluorouracil, psychotropics, and oral corticosteroids.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/24038065",
    "http://www.ncbi.nlm.nih.gov/pubmed/17698824",
    "http://www.ncbi.nlm.nih.gov/pubmed/15911722",
    "http://www.ncbi.nlm.nih.gov/pubmed/18315779",
    "http://www.ncbi.nlm.nih.gov/pubmed/20095918",
    "http://www.ncbi.nlm.nih.gov/pubmed/17119104",
    "http://www.ncbi.nlm.nih.gov/pubmed/19934391",
    "http://www.ncbi.nlm.nih.gov/pubmed/23033232",
    "http://www.ncbi.nlm.nih.gov/pubmed/22198820",
    "http://www.ncbi.nlm.nih.gov/pubmed/23089199",
    "http://www.ncbi.nlm.nih.gov/pubmed/6347619",
    "http://www.ncbi.nlm.nih.gov/pubmed/8792056",
    "http://www.ncbi.nlm.nih.gov/pubmed/27416928",
    "http://www.ncbi.nlm.nih.gov/pubmed/8672833",
    "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
    "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
    "http://www.ncbi.nlm.nih.gov/pubmed/27365092",
    "http://www.ncbi.nlm.nih.gov/pubmed/21332566"
  ],
  "snippets": [
    {
      "text": "The combined use of warfarin and NSAIDs is generally discouraged because of the increased risk of bleeding in these patients. In patients receiving warfarin who also require NSAIDs",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8672833",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The number of drugs reported to interact with warfarin continues to expand. While most reports are of poor quality and present potentially misleading conclusions, the consistency of reports of interactions with azole antibiotics, macrolides, quinolones, nonsteroidal anti-inflammatory drugs, including selective cyclooxygenase-2 inhibitors, selective serotonin reuptake inhibitors, omeprazole, lipid-lowering agents, amiodarone, and fluorouracil, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15911722",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " potential drug interaction exists between oral corticosteroids and warfarin, but there is limited documentation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17119104",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of oral corticosteroids in patients on long-term warfarin therapy may result in a clinically significant interaction, which requires close INR monitoring and possible warfarin dose reduction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17119104",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We review the possible mechanisms of this interaction and the reported interactions between warfarin and other protease inhibitors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17698824",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "It is necessary to intensify warfarin monitoring upon initiation or alteration of hormonal contraceptives.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19934391",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To report a single patient case that presented with a probable drug interaction between warfarin and 3 methods of hormonal contraceptives, as assessed by the Horn Interaction Probability Scale.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19934391",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23089199",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Several classes of drugs, such as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance of warfarin-antibiotic interactions in older adults is not clear.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23089199",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As the number of psychotropics on the market expands, the likelihood increases that a patient requiring anticoagulation with warfarin will receive concurrent treatment with a psychotropic drug.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23033232",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The most commonly identified potentially interacting medication pairs were warfarin and non-steroidal anti-inflammatory drugs (6824 cases), theophylline/aminophylline and ciprofloxacin/fluvoxamine (930), and warfarin and barbiturates (567).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18315779",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Among 36 drugs that may interact with warfarin, fluconazole, amiodarone, and omeprazole were associated with the requirement for 45.8, 16.7, and 16.7% lower median warfarin dose (all P<0.05 with a false discovery rate <0.05).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22198820",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The results demonstrate a high prevalence of concomitant drug prescriptions with the potential for clinically relevant DDIs with warfarin, the most frequent being acetylsalicylic acid and amiodarone",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27365092",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We provide new support for the previous scarce evidence of interactions between warfarin and carbamazepine, bezafibrate, and lactulose. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24038065",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Noteworthy are the interactions with cardiovascular or antilipidaemic drugs which are often coadministered with coumarins: amiodarone, propafenone and fibrates. Cardiovascular drugs which are obviously devoid or proven to be devoid of an interaction are angiotensin converting enzyme (ACE) inhibitors, calcium antagonists, beta-blockers and cardiac glycosides.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8792056",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Of the antidepressants analyzed, those that showed relevant effects on the interaction with warfarin were, in decreasing order: paroxetine, venlafaxine, fluoxetine, and duloxetine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Isomeric differences in metabolism form an important basis for stereoselective metabolic interactions, especially inhibition; this has been demonstrated with phenylbutazone, metronidazole and co-trimoxazole",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/6347619",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21332566",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A retrospective case series published in 2012 concluded that miconazole and nystatin used as topical antifungal drugs appear to interact equally strongly with warfarin.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416928",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " trazodone (2.2%) and carbamazepine (1.1%). The most commonly prescribed agents independently associated with increased bleeding risk were cyclooxygenase-2 inhibitors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Metabolic interaction between warfarin and antiretrovirals is likely, particularly if NNRTIs or PIs are included in the antiretroviral regimen.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20095918",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://meshb.nlm.nih.gov/record/ui?ui=D018565",
    "https://meshb.nlm.nih.gov/record/ui?ui=D014859",
    "http://www.biosemantics.org/jochem#4250139"
  ],
  "exact_answer": "SSRI, antibiotics, NSAIDS, antimetabolites, oral corticosteroids, protease inhibitors, psychotropics, statins/lipid lowering drugs, omeprazole, amiodarone, carbamazapine, narcotics/opiods, cardiovascular drugs, trazodone, antifungals, antivirals"
}